货号:A483760
同义名:
IRE1 Inhibitor IV; IRE1α Kinase Inhibiting RNase Attenuator 6
In INS-1 cells, KIRA6 inhibits IRE1α auto-phosphorylation by Tg and XBP1 mRNA splicing by Tm in a dose-dependent manner.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | KIRA6 is highlighted as a sophisticated small-molecule inhibitor targeting the IRE1α RNase kinase, displaying an IC50 of 0.6 µM[2]. |
Animal study | Administered via intraperitoneal injection at 5 mg/kg for 37 days, KIRA6 notably improves random glucose levels over time when compared to a vehicle, under a free-feeding regimen[2].Also, following 21 or 18 days post-injections, it elevates plasma insulin and C-peptide levels and sustains high levels of insulin-positive islet areas in the Akita Mouse, demonstrating its efficacy in glucose management and insulin secretion enhancement[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.93mL 0.39mL 0.19mL |
9.64mL 1.93mL 0.96mL |
19.29mL 3.86mL 1.93mL |
CAS号 | 1589527-65-0 |
分子式 | C28H25F3N6O |
分子量 | 518.53 |
SMILES Code | O=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=C3C=CC=CC3=C(C4=C5C(N)=NC=CN5C(C(C)(C)C)=N4)C=C2 |
MDL No. | MFCD29477497 |
别名 | IRE1 Inhibitor IV; IRE1α Kinase Inhibiting RNase Attenuator 6 |
运输 | 蓝冰 |
InChI Key | NOHQEAFAESMMDX-UHFFFAOYSA-N |
Pubchem ID | 73425700 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|